Personalis share price today

(PSNL)

Personalis share price is $6.09 & ₹518.86 as on 25 Dec 2024, 2.30 'hrs' IST

$6.09

▲

0.14

(2.35%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Personalis share price in Dollar and Rupees. Guide to invest in Personalis from India. Also see the sentimental analysis on Indian investors investing in Personalis. Get details on the Indian mutual funds that are investing in Personalis. Get Analyst recommendations and forecasts along with all the Personalis's financials.

Personalis share price movements

Today's Low: $5.63
Today's High: $6.16
$6.09
7.51%
Downside
Day's Volatility :8.56%
Upside
1.14%
52 Weeks Low: $1.12
52 Weeks High: $7.20
$6.09
81.61%
Downside
52 Weeks Volatility :84.44%
Upside
15.42%

Personalis Returns

Period	Personalis Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	18.02%	-9.0%	0.0%
6 Months	403.31%	-4.6%	0.0%
1 Year	200.0%	3.0%	0.0%
3 Years	-55.25%	0.0%	-21.1%

Personalis Key Statistics

in dollars & INR

Previous Close	$5.95
Open	$5.96
Today's High	$6.16
Today's Low	$5.6325
Market Capitalization	$515.8M
Today's Volume	$896.5K
52 Week High	$7.2
52 Week Low	$1.12
Revenue TTM	$87.5M
EBITDA	$-58.8M
Earnings Per Share (EPS)	$-1.73
Profit Margin	-104.52%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-57.52%

How to invest in Personalis from India?

It is very easy for Indian residents to invest directly in Personalis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Personalis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Personalis or PSNL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Personalis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Personalis shares which would translate to 0.140 fractional shares of Personalis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Personalis, in just a few clicks!

Returns in Personalis for Indian investors in Rupees

Investment Value

₹1,00,000

Personalis investment value today

Current value as on today

₹3,02,239

Returns

₹2,02,239

(+202.24%)

Returns from Personalis Stock

₹2,00,000 (+200%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Personalis

52%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Personalis on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 52% more investors are searching Personalis in the last 30 days versus the previous period.

Global Institutional Holdings in Personalis

ARK Investment Management LLC
10.03%
AIGH Capital Management, LLC
5.66%
BlackRock Inc
4.66%
Millennium Management LLC
3.45%
Vanguard Group Inc
2.79%
Blue Water Life Science Advisors, LLC
1.42%

Analyst Recommendation on Personalis

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Personalis(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Personalis

What analysts predicted

Upside of 24.53%

Current:

$6.09

Target:

$7.58

Insights on Personalis

Price Movement
In the last 6 months, PSNL stock has moved up by 413.9%
Increasing Revenue
Revenue is up for the last 3 quarters, 19.52M → 25.70M (in $), with an average increase of 12.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -12.80M → -39.08M (in $), with an average decrease of 205.3% per quarter
PSNL vs A (3 yr)
In the last 3 years, Personalis Inc has experienced a drawdown of -57.6%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 38.9%

Personalis Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$37.8M	↑ 302.15%
Net Income	$-19.9M	↓ 15.73%
Net Profit Margin	-52.64%	↑ 198.59%

	FY19	Y/Y Change
Revenue	$65.2M	↑ 72.62%
Net Income	$-25.1M	↑ 26.14%
Net Profit Margin	-38.47%	↑ 14.17%

	FY20	Y/Y Change
Revenue	$78.6M	↑ 20.61%
Net Income	$-41.3M	↑ 64.57%
Net Profit Margin	-52.49%	↓ 14.02%

	FY21	Y/Y Change
Revenue	$85.5M	↑ 8.7%
Net Income	$-65.2M	↑ 58.01%
Net Profit Margin	-76.29%	↓ 23.8%

	FY22	Y/Y Change
Revenue	$65.0M	↓ 23.92%
Net Income	$-113.3M	↑ 73.73%
Net Profit Margin	-174.2%	↓ 97.91%

	FY23	Y/Y Change
Revenue	$73.5M	↑ 12.97%
Net Income	$-108.3M	↓ 4.43%
Net Profit Margin	-147.38%	↑ 26.82%

	Q2 FY23	Q/Q Change
Revenue	$16.7M	↓ 11.46%
Net Income	$-24.0M	↓ 16.41%
Net Profit Margin	-143.45%	↑ 8.51%

	Q3 FY23	Q/Q Change
Revenue	$18.2M	↑ 9.27%
Net Income	$-29.1M	↑ 21.47%
Net Profit Margin	-159.47%	↓ 16.02%

	Q4 FY23	Q/Q Change
Revenue	$19.7M	↑ 7.83%
Net Income	$-26.6M	↓ 8.64%
Net Profit Margin	-135.12%	↑ 24.35%

	Q1 FY24	Q/Q Change
Revenue	$19.5M	↓ 0.76%
Net Income	$-13.0M	↓ 51.22%
Net Profit Margin	-66.42%	↑ 68.7%

	Q2 FY24	Q/Q Change
Revenue	$22.6M	↑ 15.65%
Net Income	$-12.8M	↓ 1.28%
Net Profit Margin	-56.7%	↑ 9.72%

	Q3 FY24	Q/Q Change
Revenue	$25.7M	↑ 13.86%
Net Income	$-39.1M	↑ 205.34%
Net Profit Margin	-152.04%	↓ 95.34%

	FY18	Y/Y Change
Profit	$11.8M	↓ 603.84%

	FY19	Y/Y Change
Profit	$22.1M	↑ 87.04%

	FY20	Y/Y Change
Profit	$20.1M	↓ 8.9%

	FY21	Y/Y Change
Profit	$31.7M	↑ 57.39%

	FY22	Y/Y Change
Profit	$13.4M	↓ 57.83%

	FY23	Y/Y Change
Profit	$18.2M	↑ 36.39%

	Q2 FY23	Q/Q Change
Profit	$4.8M	↑ 1.31%

	Q3 FY23	Q/Q Change
Profit	$3.5M	↓ 27.36%

	Q4 FY23	Q/Q Change
Profit	$5.2M	↑ 49.53%

	Q1 FY24	Q/Q Change
Profit	$5.5M	↑ 5.53%

	Q2 FY24	Q/Q Change
Profit	$8.0M	↑ 46.31%

	Q3 FY24	Q/Q Change
Profit	$8.7M	↑ 8.81%

	FY18	Y/Y Change
Operating Cash Flow	$5.6M	↑ 1821.38%
Investing Cash Flow	$-7.9M	↑ 52.23%
Financing Cash Flow	$-591.0K	↓ 103.6%

	FY19	Y/Y Change
Operating Cash Flow	$-18.1M	↓ 424.28%
Investing Cash Flow	$-81.6M	↑ 938.96%
Financing Cash Flow	$134.9M	↓ 22933.84%

	FY20	Y/Y Change
Operating Cash Flow	$-42.7M	↑ 136.06%
Investing Cash Flow	$-65.1M	↓ 20.15%
Financing Cash Flow	$121.3M	↓ 10.14%

	FY21	Y/Y Change
Operating Cash Flow	$-70.8M	↑ 66.06%
Investing Cash Flow	$-60.1M	↓ 7.79%
Financing Cash Flow	$169.7M	↑ 39.94%

	FY22	Y/Y Change
Operating Cash Flow	$-70.2M	↓ 0.84%
Investing Cash Flow	$52.5M	↓ 187.46%
Financing Cash Flow	$1.4M	↓ 99.2%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-10.4M	↓ 33.86%
Investing Cash Flow	$19.5M	↑ 41.73%
Financing Cash Flow	$925.0K	↑ 0.0%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-16.7M	↑ 60.18%
Investing Cash Flow	$-8.6M	↓ 144.02%
Financing Cash Flow	$290.0K	↓ 68.65%

Personalis Technicals Summary

Sell

Neutral

Buy

Personalis is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Personalis Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Personalis Inc	63.27%	403.31%	200.0%	-55.25%	-39.22%
Idexx Laboratories, Inc.	-0.89%	-16.26%	-25.76%	-36.84%	58.11%
Agilent Technologies Inc.	1.29%	4.05%	-2.66%	-14.26%	60.31%
Thermo Fisher Scientific, Inc.	3.12%	-3.96%	-0.5%	-20.12%	62.74%
Danaher Corp.	-2.46%	-8.35%	-0.91%	-29.52%	50.97%
Iqvia Holdings Inc.	-0.62%	-6.0%	-13.77%	-29.1%	30.33%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Personalis Inc	NA	NA	NA	-1.44	-0.58	-0.19	NA	2.36
Idexx Laboratories, Inc.	40.0	40.0	4.35	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	30.79	30.79	2.31	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	33.1	33.1	2.0	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	43.46	43.46	3.06	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.25	26.25	1.06	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Personalis Inc	Buy	$515.8M	-39.22%	NA	-104.52%
Idexx Laboratories, Inc.	Buy	$33.9B	58.11%	40.0	22.53%
Agilent Technologies Inc.	Buy	$38.9B	60.31%	30.79	21.75%
Thermo Fisher Scientific, Inc.	Buy	$202.3B	62.74%	33.1	14.48%
Danaher Corp.	Buy	$166.7B	50.97%	43.46	16.39%
Iqvia Holdings Inc.	Buy	$36.3B	30.33%	26.25	9.17%

About Personalis

personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.

Organization	Personalis
Employees	223
CEO	Mr. Christopher M. Hall
Industry	Biotechnology

Management People of Personalis

Name	Title
Mr. Christopher M. Hall	President, CEO & Director
Mr. Aaron L. Tachibana	CFO & COO
Mr. Stephen M. Moore J.D.	Senior VP & Chief Legal Officer
Dr. Richard Chen M.D., M.S.	Executive VP of R&D and Chief Medical Officer
Dr. Russ B. Altman M.D., Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
Dr. Euan A. Ashley DPHIL, FRCP, M.D., Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
Dr. Michael P. Snyder Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
Mr. Michael J Fitzpatrick	Vice President of Worldwide Sales
Dr. Christian Haudenschild Ph.D.	Senior Vice President of Genomic Laboratory Operations
Mr. Stephane Mouradian Ph.D.	Senior Vice President of Business Development

Important FAQs about investing in Personalis from India :

What is Personalis share price today?

Personalis share price today stands at $6.09, Open: $5.96 ; Previous Close: $5.95 ; High: $6.16 ; Low: $5.63 ; 52 Week High: $7.20 ; 52 Week Low: $1.12. The stock opens at $5.96, after a previous close of $5.95. The stock reached a daily high of $6.16 and a low of $5.63, with a 52-week high of $7.20 and a 52-week low of $1.12.

Can Indians buy Personalis shares?

Yes, Indians can invest in the Personalis (PSNL) from India.

With INDmoney, you can buy Personalis at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Personalis at zero transaction cost.

How can I buy Personalis shares from India?

It is very easy to buy Personalis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Personalis be purchased?

Yes, you can buy fractional shares of Personalis with INDmoney app.

What are the documents required to start investing in Personalis stocks?

To start investing in Personalis, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.